Navigation Links
Reversibility of symptoms of depression using CPAP in patients with obstructive sleep apnea

Depression and obstructive sleep apnea share some common symptoms, due to which physicians often tend to get confused in the correct diagnosis. Obstructive sleep apnea (OSA) occurs when the tongue or throat muscles // relax too much during sleep and block the airway. This can happen more than 50 times an hour during sleep, causing snoring and pauses in breathing that last as long as 60 seconds. The problem is twice as common in men, and it afflicts more than 12 million Americans, according to the National Institutes of Health. Sleep apnea is usually treated by wearing a mask or using a specially designed nasal device that delivers air under slight pressure, keeping the airway open so that the patient can breathe normally.

A study was undertaken at The Sleep Center at University Community Hospital, Tampa, FL to assess the reversibility of symptoms of depression using continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA). The findings, published in the September issue of the journal Chest, report that many patients with depression symptoms improved markedly when treated with continuous positive airway pressure, or CPAP therapy, the standard treatment for sleep apnea.

Patients referred to our center for evaluation of OSA who had a respiratory disturbance index (RDI) and who demonstrated a significant response to CPAP were evaluated for the symptoms of depression using the Beck Depression Inventory (BDI), and then reassessed after 4 to 6 weeks of treatment with CPAP at home. In this group of patients, the institution of CPAP therapy resulted in a significant decrease in those symptoms of depression. This change in was noted both in those individuals who had received an antidepressant prescription prior to referral, and in those who had not.

However, the authors warn that this finding does not necessarily apply to all patients with depression, and conversely, not everyone who has depression symptoms should automatically be evaluated for a sleep disorder. It is quite possible that depression and sleep apnea share the same underlying mechanisms, or that obstructive sleep apnea is itself a cause of depression.

It is suggested that patients under depression should disclose symptoms suggestive of obstructive sleep apnea to their physicians. In some of these individuals, the symptoms of depression may be ameliorated with CPAP.


'"/>




Related medicine news :

1. Cell transplants used to fend off Parkinsons symptoms
2. Occupational exposurer aises respiratory symptoms
3. New drug to multiple sclerosis symptoms
4. Warding off symptoms of premenstrual syndrome by combination therapy
5. Women who had stopped HRT get back their symptoms
6. Beat menopausal symptoms with low-dose estrogen
7. Dark chocolate can help ease symptoms of diarrhea
8. Synthetic protein found to relieve arthritis symptoms in animal model
9. Physical activity may help relieve gastrointestinal symptoms in obese people
10. Pubertal development may predispose women to pain and other symptoms
11. Exposure to Chill can result in common cold symptoms
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... , Oct. 4, 2017 ... single-use, self-contained, illuminating medical devices, today announced regulatory ... Health Surveillance Agency (or Agência Nacional de Vigilância ... first single-use, cordless surgical retractor with integrated LED ... optimal access, illumination and exposure of a tissue ...
(Date:10/2/2017)... -- The Rebound mobile app is poised to become a ... of prescription drug addiction. The app empowers users to develop ... down their dosage in a safe, controlled manner while maximizing ... first 100,000 people to sign up will enjoy 3 months ... ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
Breaking Medicine Technology: